- Amikacin therapy for urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
-
Cho SY, Choi SM, Park SH, Lee DG, Choi JH, Yoo JH
- KMID: 2373784
- Korean J Intern Med.
- 2016 Jan;31(1):156-161.
- doi: 10.3904/kjim.2016.31.1.156
BACKGROUND/AIMS: The number of urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) is increasing. In an outpatient setting, there are limited therapeutic options to treat ESBL-producing pathogens.... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli
-
Chang UI, Kim HW, Wie SH
- KMID: 2373783
- Korean J Intern Med.
- 2016 Jan;31(1):145-155.
- doi: 10.3904/kjim.2016.31.1.145
BACKGROUND/AIMS: Efforts to decrease the use of extended-spectrum cephalosporins are required to prevent the selection and transmission of multi-drug resistant pathogens, such as extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. The objectives of... -
- CITED
-
- Close
- SHARE
-
- Close
